|
1
|
Guo G, von Meyenn F, Santos F, Chen Y,
Reik W, Bertone P, Smith A and Nichols J: Naive pluripotent stem
cells derived directly from isolated cells of the human inner cell
mass. Stem Cell Reports. 6:437–446. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu Z and Huangfu D: Human pluripotent
stem cells: An emerging model in developmental biology.
Development. 140:705–717. 2013. View Article : Google Scholar :
|
|
3
|
Correia C, Koshkin A, Carido M, Espinha N,
Šarić T, Lima PA, Serra M and Alves PM: Effective hypothermic
storage of human pluripotent stem cell-derived cardiomyocytes
compatible with global distribution of cells for clinical
applications and toxicology testing. Stem Cells Transl Med.
5:658–669. 2016. View Article : Google Scholar
|
|
4
|
Choudhary P, Booth H, Gutteridge A,
Surmacz B, Louca I, Steer J, Kerby J and Whiting PJ: Directing
differentiation of pluripotent stem cells toward retinal pigment
epithelium lineage. Stem Cells Transl Med. 6:490–501. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li P, Yang YM, Sanchez S, Cui DC, Dang RJ,
Wang XY, Lin QX, Wang Y, Wang C, Chen DF, et al: Deubiquitinase
MYSM1 is essential for normal bone formation and mesenchymal stem
cell differentiation. Sci Rep. 6:222112016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dang PN, Dwivedi N, Phillips LM, Yu X,
Herberg S, Bowerman C, Solorio LD, Murphy WL and Alsberg E:
Controlled dual growth factor delivery from microparticles
incorporated within human bone marrow-derived mesenchymal stem cell
aggregates for enhanced bone tissue engineering via endochondral
ossification. Stem Cells Transl Med. 5:206–217. 2016. View Article : Google Scholar
|
|
7
|
Cheng YC, Huang CJ, Lee YJ, Tien LT, Ku
WC, Chien R, Lee FK and Chien CC: Knocking down of heat-shock
protein 27 directs differentiation of functional glutamatergic
neurons from placenta-derived multipotent cells. Sci Rep.
6:303142016. View Article : Google Scholar
|
|
8
|
Silva-Vargas V, Maldonado-Soto AR, Mizrak
D, Codega P and Doetsch F: Age-dependent niche signals from the
choroid plexus regulate adult neural stem cells. Cell Stem Cell.
19:643–652. 2016. View Article : Google Scholar
|
|
9
|
Hu K and Olsen BR: Osteoblast-derived VEGF
regulates osteoblast differentiation and bone formation during bone
repair. J Clin Invest. 126:509–526. 2016. View Article : Google Scholar
|
|
10
|
Jones DR: A potential osteoporosis target
in the FAS ligand/FAS pathway of osteoblast to osteoclast
signaling. Ann Transl Med. 3:1892015.
|
|
11
|
Bliuc D, Nguyen ND, Alarkawi D, Nguyen TV,
Eisman JA and Center JR: Accelerated bone loss and increased
post-fracture mortality in elderly women and men. Osteoporos Int.
26:1331–1339. 2015. View Article : Google Scholar
|
|
12
|
Pacifici R: Estrogen, cytokines, and
Sathogenesis of SostPeno-pausal osteoporosis. J Bone Miner Res.
11:1043–1051. 1996. View Article : Google Scholar
|
|
13
|
Tanaka SM and Tachibana K:
Frequency-dependence of mechanically stimulated osteoblastic
calcification in tissue-engineered bone in vitro. Ann Biomed Eng.
43:2083–2089. 2015. View Article : Google Scholar
|
|
14
|
Amin Yavari S, Chai YC, Böttger AJ,
Wauthle R, Schrooten J, Weinans H and Zadpoor AA: Effects of
anodizing parameters and heat treatment on nanotopographical
features, bioactivity, and cell culture response of additively
manufactured porous titanium. Mater Sci Eng C Mater Biol Appl.
51:132–138. 2015. View Article : Google Scholar
|
|
15
|
Azuma K, Shiba S, Hasegawa T, Ikeda K,
Urano T, Horie-Inoue K, Ouchi Y, Apizuka N and Inoue S: Osteoblast
sSecific γ-glutamyl carboxylase deficient Pice disSlay enhanced
bone forPation with aberrant mineralization. J Bone Miner Res.
30:1245–1254. 2015. View Article : Google Scholar
|
|
16
|
Nakamura T, Naruse M, Chiba Y, Komori T,
Sasaki K, Iwamoto M and Fukumoto S: Novel hedgehog agonists promote
osteoblast differentiation in mesenchymal stem cells. J Cell
Physiol. 230:922–929. 2015. View Article : Google Scholar
|
|
17
|
Joensuu K, Uusitalo L, Alm JJ, Aro HT,
Hentunen TA and Heino TJ: Enhanced osteoblastic differentiation and
bone formation in co-culture of human bone marrow mesenchymal
stromal cells and peripheral blood mononuclear cells with exogenous
VEGF. Orthop Traumatol Surg Res. 101:381–386. 2015. View Article : Google Scholar
|
|
18
|
Willson T, Nelson SD, Newbold J, Nelson RE
and LaFleur J: The clinical epidemiology of male osteoporosis: A
review of the recent literature. Clin Epidemiol. 7:65–76. 2015.
|
|
19
|
Canalis E: MANAGEMENT OF ENDOCRINE
DISEASE: Novel anabolic treatments for osteoporosis. Eur J
Endocrinol. 178:R33–R44. 2018. View Article : Google Scholar
|
|
20
|
Ragsdale AB, Barringer TA III and
Anastasio GD: Alendronate treatment to prevent osteoporotic
fractures. Arch Fam Med. 7:583–586. 1998. View Article : Google Scholar
|
|
21
|
Kanis JA, Gertz BJ, Singer F and Ortolani
S: Rationale for the use of alendronate in osteoporosis. Osteoporos
Int. 5:1–13. 1995. View Article : Google Scholar
|
|
22
|
Drake MT, Clarke BL and Khosla S:
Bisphosphonates: Mechanism of action and role in clinical practice.
Mayo Clin Proc. 83:1032–1045. 2008. View Article : Google Scholar
|
|
23
|
Gertz BJ, Holland SD, Kline WF,
Matuszewski BK and Porras AG: Clinical pharmacology of alendronate
sodium. Osteoporos Int. 3(Suppl 3): S13–S16. 1993. View Article : Google Scholar
|
|
24
|
Porras AG, Holland SD and Gertz BJ:
Pharmacokinetics of alendronate. Clin Pharmacokinet. 36:315–328.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sui B, Hu C, Zhang X, Zhao P, He T, Zhou
C, Qiu X, Chen N, Zhao X and Jin Y: Allogeneic mesenchymal stem
cell therapy promotes osteoblastogenesis and prevents
glucocorticoid-induced osteoporosis. Stem Cells Transl Med.
5:1238–1246. 2016. View Article : Google Scholar :
|
|
26
|
Qi X, Zhang J, Yuan H, Xu Z, Li Q, Niu X,
Hu B, Wang Y and Li X: Exosomes secreted by human-induced
pluripotent stem cell-derived mesenchymal stem cells repair
critical-sized bone defects through enhanced angiogenesis and
osteogenesis in osteoporotic rats. Int J Biol Sci. 12:836–849.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng CC, Chung CA, Su LC, Chien CC and
Cheng YC: Osteogenic differentiation of placenta-derived
multipotent cells in vitro. Taiwan J Obstet Gynecol. 53:187–192.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Selim AO, Selim SA, Shalaby SM, Mosaad H
and Saber T: Neuroprotective effects of placenta-derived
mesenchymal stromal cells in a rat model of experimental autoimmune
encephalomyelitis. Cytotherapy. 18:1100–1113. 2016. View Article : Google Scholar
|
|
29
|
Chien CC, Yen BL, Lee FK, Lai TH, Chen YC,
Chan SH and Huang HI: In vitro differentiation of human
placenta-derived multipotent cells into hepatocyte-like cells. Stem
Cells. 24:1759–1768. 2006. View Article : Google Scholar
|
|
30
|
Yen BL, Huang HI, Chien CC, Jui HY, Ko BS,
Yao M, Shun CT, Yen ML, Lee MC and Chen YC: Isolation of
multipotent cells from human term placenta. Stem Cells. 23:3–9.
2005. View Article : Google Scholar
|
|
31
|
Lv FJ, Tuan RS, Cheung KM and Leung VY:
Concise review: The surface markers and identity of human
mesenchymal stem cells. Stem Cells. 32:1408–1419. 2014. View Article : Google Scholar
|
|
32
|
Ali H, Al-Yatama MK, Abu-Farha M,
Behbehani K and Al Madhoun A: Multi-lineage differentiation of
human umbilical cord Wharton's Jelly Mesenchymal Stromal cells
mediates changes in the exSression Srofile of stePness Parkers.
PLoS One. 10:e01224652015. View Article : Google Scholar
|
|
33
|
Wrobel E, Leszczynska J and Brzoska E: The
characteristics of human bone-derived cells (HBDCS) during
osteogenesis in vitro. Cell Mol Biol Lett. 21:262016. View Article : Google Scholar
|
|
34
|
Benisch P, Schilling T, Klein-Hitpass L,
Frey SP, Seefried L, Raaijmakers N, Krug M, Regensburger M, Zeck S,
Schinke T, et al: The transcriStional Srofile of PesenchyPal steP
cell populations in primary osteoporosis is distinct and shows
overexpression of osteogenic inhibitors. PLoS One. 7:e451422012.
View Article : Google Scholar
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
36
|
Huang CJ, Lee CL, Yang SH, Chien CC, Huang
CC, Yang RN and Chang CC: USregulation of the growth arrest
sSecific 2 in recurrent colorectal cancers, and its susceptibility
to chemotherapy in a model cell system. Biochim Biophys Acta.
1862:1345–1353. 2016. View Article : Google Scholar
|
|
37
|
Chen T, Mao H, Chen C, Wu L, Wang N, Zhao
X, Qian J and Xing C: The role and mechanism of α Klotho in the
calcification of rat aortic vascular smooth muscle cells. Biomed
Res Int. 2015:1943622015. View Article : Google Scholar
|
|
38
|
Kaji H, Naito J, Sowa H, Sugimoto T and
Chihara K: Smad3 differently affects osteoblast differentiation
depending upon its differentiation stage. Horm Metab Res.
38:740–745. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sowa H, Kaji H, Yamaguchi T, Sugimoto T
and Chihara K: Smad3 promotes alkaline phosphatase activity and
mineralization of osteoblastic MC3T3-E1 cells. J Bone Miner Res.
17:1190–1199. 2002. View Article : Google Scholar
|
|
40
|
Jinnin M, Ihn H and Tamaki K:
Characterization of SIS3, a novel sSecific inhibitor of SPad3, and
its effect on transforPing growth factor-beta1-induced
extracellular matrix expression. Mol Pharmacol. 69:597–607. 2006.
View Article : Google Scholar
|
|
41
|
Yang P, Lv S, Wang Y, Peng Y, Ye Z, Xia Z,
Ding G, Cao X and Crane JL: Preservation of type H vessels and
osteoblasts by enhanced preosteoclast platelet-derived growth
factor type BB attenuates glucocorticoid-induced osteoporosis in
growing mice. Bone. 114:1–13. 2018. View Article : Google Scholar
|
|
42
|
Khan MP, Singh AK, Singh AK, Shrivastava
P, Tiwari MC, Nagar GK, Bora HK, Parameswaran V, Sanyal S, Bellare
JR and Chattopadhyay N: Odanacatib restores trabecular bone of
skeletally mature female rabbits with osteopenia but induces
brittleness of cortical bone: A comparative study of the
investigational drug with PTH, Estrogen, and Alendronate. J Bone
Miner Res. 31:615–629. 2016. View Article : Google Scholar
|
|
43
|
Ishijima M, Sakamoto Y, Yamanaka M, Tokita
A, Kitahara K, Kaneko H and Kurosawa H: Minimum required vitamin D
level for optimal increase in bone mineral density with alendronate
treatment in osteoporotic women. Calcif Tissue Int. 85:398–404.
2009. View Article : Google Scholar
|
|
44
|
Park JH, Park KH, Cho S, Choi YS, Seo SK,
Lee BS and Park HS: Concomitant increase in muscle strength and
bone mineral density with decreasing IL-6 levels after combination
therapy with alendronate and calcitriol in postmenopausal women.
Menopause. 20:747–753. 2013. View Article : Google Scholar
|
|
45
|
Chou MT, Chang SN, Ke C, Chang HI, Sung
ML, Kuo HC and Chen CN: The proliferation and differentiation of
placental-derived multipotent cells into smooth muscle cells on
fibrillar collagen. BioPaterials. 31(4367): 43752010.
|
|
46
|
Sun J, Li J, Li C and Yu Y: Role of bone
morphogenetic protein-2 in osteogenic differentiation of
mesenchymal stem cells. Mol Med Rep. 12:4230–4237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ho SS, Vollmer NL, Refaat MI, Jeon O,
Alsberg E, Lee MA and Leach JK: Bone morphogenetic protein-2
promotes human mesenchymal stem cell survival and resultant bone
formation when entrapped in photocrosslinked alginate hydrogels.
Adv Healthc Mater. 5:2501–2509. 2016. View Article : Google Scholar
|
|
48
|
Baas J, Vestermark M, Jensen T, Bechtold
J, Soballe K and Jakobsen T: Topical bisphosphonate augments
fixation of bone-grafted hydroxyapatite coated implants, BMP-2
causes resorption-based decrease in bone. Bone. 97:76–82. 2017.
View Article : Google Scholar
|
|
49
|
Liu Z, Yao X, Yan G, Xu Y, Yan J, Zou W
and Wang G: Mediator MED23 cooperates with RUNX2 to drive
osteoblast differentiation and bone development. Nat Commun.
7:111492016. View Article : Google Scholar
|
|
50
|
Zhao L, Jiang S and Hantash BM:
Transforming growth factor beta1 induces osteogenic differentiation
of murine bone marrow stromal cells. Tissue Eng Part A. 16:725–733.
2010. View Article : Google Scholar
|
|
51
|
Genge BR, Sauer GR, Wu LN, McLean FM and
Wuthier RE: Correlation between loss of alkaline phosphatase
activity and accumulation of calcium during matrix vesicle-mediated
mineralization. J Biol Chem. 263:18513–18519. 1988.PubMed/NCBI
|
|
52
|
Bobryshev YV, Orekhov AN, Sobenin I and
Chistiakov DA: Role of bone-type tissue-nonspecific alkaline
phosphatase and PHOSPO1 in vascular calcification. Curr PharP Des.
20:5821–5828. 2014. View Article : Google Scholar
|
|
53
|
Sila-Asna M, Bunyaratvej A, Maeda S,
Kitaguchi H and Bunyaratavej N: Osteoblast differentiation and bone
formation gene expression in strontium-inducing bone marrow
mesenchymal stem cell. Kobe J Med Sci. 53:25–35. 2007.
|
|
54
|
Birmingham E, Niebur GL, McHugh PE, Shaw
G, Barry FP and McNamara LM: Osteogenic differentiation of
mesenchymal stem cells is regulated by osteocyte and osteoblast
cells in a siPSlified bone niche. Eur Cell Mater. 23:13–27. 2012.
View Article : Google Scholar
|
|
55
|
Yu Y, Yang JL, Chapman-Sheath PJ and Walsh
WR: TGF-beta, BMPS, and their signal transducing mediators, Smads,
in rat fracture healing. J Biomed Mater Res. 60:392–397. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen G, Deng C and Li YP: TGF-β and BMP
signaling in osteoblast differentiation and bone formation. Int J
Biol Sci. 8:272–288. 2012. View Article : Google Scholar
|
|
57
|
Bonniaud P, Margetts PJ, Ask K, Flanders
K, Gauldie J and Kolb M: TGF beta and SPad3 signaling link
inflaPPation to chronic fibrogenesis. J IPPunol. 175(5390):
53952005.
|
|
58
|
Qin W, Chung AC, Huang XR, Meng XM, Hui
DS, Yu CM, Sung JJ and Lan HY: TGF-β/Smad3 signaling promotes renal
fibrosis by inhibiting PiR 29. J AP Soc NeShrol. 22(1462):
14742011.
|
|
59
|
Dobaczewski M, Bujak M, Li N, Gonzalez
Quesada C, Mendoza LH, Wang XF and Frangogiannis NG: Smad3
signaling critically regulates fibroblast ShenotySe and function in
healing myocardial infarction. Circ Res. 107:418–428. 2010.
View Article : Google Scholar :
|
|
60
|
Flanders KC, Major CD, Arabshahi A,
Aburime EE, Okada MH, Fujii M, Blalock TD, Schultz GS, Sowers A,
Anzano MA, et al: Interference with transforming growth
factor-beta/Smad3 signaling results in accelerated healing of
wounds in previously irradiated skin. Am J Pathol. 163:2247–2257.
2003. View Article : Google Scholar
|
|
61
|
Borton AJ, Frederick JP, Datto MB, Wang XF
and Weinstein RS: The loss of Smad3 results in a lower rate of bone
formation and osteopenia through dysregulation of osteoblast
differentiation and apoptosis. J Bone Miner Res. 16:1754–1764.
2001. View Article : Google Scholar
|
|
62
|
Yu FY, Xie CQ, Sun JT, Peng W and Huang
XW: OverexSressed miR-145 inhibits osteoclastogenesis in
RANKL-induced bone marrow-derived macrophages and ovariectomized
mice by regulation of Smad3. Life Sci. 202:11–20. 2018. View Article : Google Scholar
|
|
63
|
Tamai R and Kiyoura Y: Alendronate
augments lipid A-induced IL-1β release and
Smad3/NLRP3/ASC-dependent cell death. Life Sci. 198:8–17. 2018.
View Article : Google Scholar
|
|
64
|
Tamai R, Sugiyama A and Kiyoura Y:
Alendronate regulates cytokine production induced by lipid A
through nuclear factor-κB and SPad3 activation in huPan gingival
fibroblasts. J Periodontal Res. 46:13–20. 2011. View Article : Google Scholar
|
|
65
|
Rizzoli R, Greenspan SL, Bone G III,
Schnitzer TJ, Watts NB, Adami S, Foldes AJ, Roux C, Levine MA,
Uebelhart B, et al: Two-year results of once-weekly administration
of alendronate 70 mg for the treatment of postmenopausal
osteoporosis. J Bone Miner Res. 17:1988–1996. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Uchida S, Taniguchi T, Shimizu T, Kakikawa
T, Okuyama K, Okaniwa M, Arizono H, Nagata K, Santora AC, Shiraki
M, et al: Therapeutic effects of alendronate 35 mg once weekly and
5 mg once daily in Japanese patients with osteoporosis: A
double-blind, randomized study. J Bone Miner Metab. 23:382–388.
2005. View Article : Google Scholar
|
|
67
|
Du X, Huang F, Zhang S, Yao Y, Chen Y,
Chen Y, Huang H and Bai B: Carboxymethylcellulose with phenolic
hydroxyl micro-caSsules enclosinggene Podified BMSCs for controlled
BMP 2 release in vitro. Artif Cells Nanomed Biotechnol.
45:1710–1720. 2017. View Article : Google Scholar
|
